Now Playing
Opinion|Videos|May 29, 2024
Harnessing the Power of VR for Visual Field Testing: Results of The NOVA Trial
Author(s)Lorraine Provencher, MD
Lorraine Provencher, MD, reviews the NOVA trial which measured and validated the sensitivity of a novel VR-based wearable headset for visual field testing in glaucoma.
Advertisement
Episodes in this series
Advertisement
Related to this article
Nora Lee Cothran, OD, FAAO, reviews a study which found a statistically significant reduction in IOP in patients with open-angle glaucoma and ocular hypertension when switching to latanoprostene bunod.
Christopher W. Lievens, OD, MS, PhD, FAAO, FNAP, FBCLA, discusses his poster presentation titled "Latanoprostene bunod 0.024% Initiation in Medicare Fee-for-Service Patients with Open Angle Glaucoma and Ocular Hypertension."
Michael Cymbor, OD, FAAO, gives an overview of a rapid fire lecture he gave in collaboration with Andrew Rixon OD, FAAO; Austin Lifferth, OD, FAAO; and Derek MacDonald, OD, FAAO, at AAOpt 2026.
Advertisement
Advertisement
Trending on Optometry Times - Clinical News & Expert Optometrist Insights
1
AAOpt 2026: Photobiomodulation to revolutionize dry AMD treatment, Dr Rafieetary says
2
AAOpt 2026: Managing complex pediatric myopia cases
3
AAOpt 2026: The real-world impact of treatment switch to latanoprostene bunod
4
AAOpt 2026: Demodex tied to worse MGD as dry eye questionnaires miss blepharitis
5